Letter to the Editor: A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine

Authors

  • John C. Hagan III, M.D., FACS, FAAO

DOI:

https://doi.org/10.17161/kjm.vol1315733

Keywords:

timolol, ophthalmic solution, migraines, letter

Metrics

File downloads
261
Jul 2021Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 20269
|

Downloads

Published

2021-03-02

Issue

Vol. 13 (2020): KJM Supplement 2: Frontiers Edition

Section

Letters to the Editor

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

How to Cite

Hagan, J. (2021). Letter to the Editor: A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine. Kansas Journal of Medicine, 13(S2), 29-30. https://doi.org/10.17161/kjm.vol1315733